134 related articles for article (PubMed ID: 20429088)
1. "Ophthalmia Venerea": A dreadful complication of fluoroquinolone-resistant Neisseria gonorrhoeae.
Guerrero ML; Alfaro IJ; Sandoval BG; Górgolas M
Sex Transm Dis; 2010 May; 37(5):340-1. PubMed ID: 20429088
[TBL] [Abstract][Full Text] [Related]
2. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
[TBL] [Abstract][Full Text] [Related]
3. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones].
Vereshchagin VA; Il'una EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
Mol Gen Mikrobiol Virusol; 2005; (1):23-7. PubMed ID: 15790029
[TBL] [Abstract][Full Text] [Related]
4. [Gonorrhea caused by fluoroquinolone resistant gonococci].
Døsen LK; Moi H
Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2783-5. PubMed ID: 9748808
[TBL] [Abstract][Full Text] [Related]
5. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.
Newman LM; Wang SA; Ohye RG; O'Connor N; Lee MV; Weinstock HS
Clin Infect Dis; 2004 Mar; 38(5):649-54. PubMed ID: 14986248
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
[TBL] [Abstract][Full Text] [Related]
9. Increasing rates of quinolone-resistant Neisseria gonorrhoeae in Paris, France.
Farhi D; Gerhardt P; Falissard B; Poupet H; Poyart C; Dupin N
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):818-21. PubMed ID: 17567314
[TBL] [Abstract][Full Text] [Related]
10. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
[TBL] [Abstract][Full Text] [Related]
11. Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
Jones RN; Biedenbach DJ; Ambrose PG; Wikler MA
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):110-2. PubMed ID: 18620833
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
Ghanem KG; Giles JA; Zenilman JM
Infect Dis Clin North Am; 2005 Jun; 19(2):351-65. PubMed ID: 15963876
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of corneal perforation secondary to gonococcal keratoconjunctivitis.
Kawashima M; Kawakita T; Den S; Tomita M; Shimazaki J
Eye (Lond); 2009 Feb; 23(2):339-44. PubMed ID: 18064057
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
[TBL] [Abstract][Full Text] [Related]
15. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
Matsumoto T
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
[TBL] [Abstract][Full Text] [Related]
17. Dual infection with Neisseria gonorrhoeae and Chlamydia trachomatis.
Moss TR; Van Der Pol B
Int J STD AIDS; 2009 Feb; 20(2):143-4. PubMed ID: 19182067
[No Abstract] [Full Text] [Related]
18. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.
Cole MJ; Chisholm SA; Hoffmann S; Stary A; Lowndes CM; Ison CA;
Sex Transm Infect; 2010 Nov; 86(6):427-32. PubMed ID: 20940154
[TBL] [Abstract][Full Text] [Related]
19. Invasive Neisseria gonorrhoeae producing pre-septal cellulitis and keratoconjunctivitis: diagnosis and management.
Varma S; Wong N; Khong JJ
Med J Aust; 2017 Sep; 207(6):269. PubMed ID: 28899333
[No Abstract] [Full Text] [Related]
20. [Treatment with amniotic membrane in keratolysis secondary to adult gonococcal keratoconjunctivitis].
Miranda-Rollón MD; Sentieri-Omarrementería A; Martínez-Rodríguez R; Junceda-Moreno C
Arch Soc Esp Oftalmol; 2009 Mar; 84(3):155-7. PubMed ID: 19340722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
